Published in Mol Biol Cell on September 01, 2000
Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J Biol Chem (2010) 1.75
Focal adhesion kinase as a regulator of cell tension in the progression of cancer. Semin Cancer Biol (2007) 1.64
Regulation of focal adhesion kinase by its amino-terminal domain through an autoinhibitory interaction. Mol Cell Biol (2003) 1.51
FAK potentiates Rac1 activation and localization to matrix adhesion sites: a role for betaPIX. Mol Biol Cell (2006) 1.42
FERM domain interaction promotes FAK signaling. Mol Cell Biol (2004) 1.34
Glycogen synthase kinase 3- and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement. Mol Cell Biol (2006) 1.26
Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol Cell Biol (2002) 1.26
FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol Biol Cell (2011) 1.22
Structural insight into the mechanisms of targeting and signaling of focal adhesion kinase. Mol Cell Biol (2002) 1.21
Multiple paxillin binding sites regulate FAK function. J Mol Signal (2008) 1.19
R-Ras promotes focal adhesion formation through focal adhesion kinase and p130(Cas) by a novel mechanism that differs from integrins. Mol Cell Biol (2003) 1.15
Focal adhesion kinase regulates cell-cell contact formation in epithelial cells via modulation of Rho. Exp Cell Res (2008) 1.04
Nudel and FAK as antagonizing strength modulators of nascent adhesions through paxillin. PLoS Biol (2009) 1.02
Focal adhesion kinase is activated in invading fibrosarcoma cells and regulates metastasis. Clin Exp Metastasis (2005) 0.90
Minimal features of paxillin that are required for the tyrosine phosphorylation of focal adhesion kinase. Biochem J (2006) 0.89
Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells. Cancer Cell Int (2008) 0.86
Activation of endogenous FAK via expression of its amino terminal domain in Xenopus embryos. PLoS One (2012) 0.82
Fibulin-1 is required for bone formation and Bmp-2-mediated induction of Osterix. Bone (2014) 0.80
The Pyk2 FERM regulates Pyk2 complex formation and phosphorylation. Cell Signal (2010) 0.80
Conformational dynamics of the focal adhesion targeting domain control specific functions of focal adhesion kinase in cells. J Biol Chem (2014) 0.79
New insights into FAK phosphorylation based on a FAT domain-defective mutation. PLoS One (2014) 0.76
Addressing the functional determinants of FAK during ciliogenesis in multiciliated cells. J Biol Chem (2016) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol (1994) 12.40
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature (1995) 11.06
pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A (1992) 8.46
Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase. Nature (1995) 8.25
Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol (1994) 7.53
Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature (1995) 6.14
Regulation of focal adhesion-associated protein tyrosine kinase by both cellular adhesion and oncogenic transformation. Nature (1992) 5.72
Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol (1995) 5.36
Focal adhesion protein-tyrosine kinase phosphorylated in response to cell attachment to fibronectin. Proc Natl Acad Sci U S A (1992) 5.06
Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase. J Biol Chem (1992) 4.33
Focal adhesion kinase and paxillin bind to peptides mimicking beta integrin cytoplasmic domains. J Cell Biol (1995) 4.26
A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature (1996) 4.23
Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol (1989) 4.08
Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol (1992) 4.06
Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci (1999) 3.93
A mechanism for regulation of the adhesion-associated proteintyrosine kinase pp125FAK. Nature (1996) 3.88
pp125FAK-dependent tyrosine phosphorylation of paxillin creates a high-affinity binding site for Crk. Mol Cell Biol (1995) 3.85
Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol (1993) 3.64
Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell (1996) 3.60
Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol Cell Biol (1996) 3.21
Direct interaction of v-Src with the focal adhesion kinase mediated by the Src SH2 domain. Mol Biol Cell (1994) 2.78
p130Cas, a substrate associated with v-Src and v-Crk, localizes to focal adhesions and binds to focal adhesion kinase. J Biol Chem (1996) 2.77
Autonomous expression of a noncatalytic domain of the focal adhesion-associated protein tyrosine kinase pp125FAK. Mol Cell Biol (1993) 2.75
Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem (1995) 2.68
Interaction between focal adhesion kinase and Crk-associated tyrosine kinase substrate p130Cas. Proc Natl Acad Sci U S A (1995) 2.67
Identification of LIM3 as the principal determinant of paxillin focal adhesion localization and characterization of a novel motif on paxillin directing vinculin and focal adhesion kinase binding. J Cell Biol (1996) 2.63
Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell (1995) 2.57
Primary sequence of paxillin contains putative SH2 and SH3 domain binding motifs and multiple LIM domains: identification of a vinculin and pp125Fak-binding region. J Cell Sci (1994) 2.43
Monoclonal antibodies specific for the carboxy terminus of simian virus 40 large T antigen. J Virol (1984) 2.41
An SH3 domain-containing GTPase-activating protein for Rho and Cdc42 associates with focal adhesion kinase. Mol Cell Biol (1996) 2.38
Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol (1996) 2.38
Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated protein kinase through interactions with and activation of c-Src. J Biol Chem (1997) 2.34
Regulation of the cell cycle by focal adhesion kinase. J Cell Biol (1998) 2.32
Inhibition of cell spreading by expression of the C-terminal domain of focal adhesion kinase (FAK) is rescued by coexpression of Src or catalytically inactive FAK: a role for paxillin tyrosine phosphorylation. Mol Cell Biol (1997) 2.29
Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem (1995) 2.26
Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J Exp Med (1995) 2.17
Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem (1995) 2.17
Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. J Biol Chem (1999) 1.91
SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem (1998) 1.77
Characterisation of the paxillin-binding site and the C-terminal focal adhesion targeting sequence in vinculin. J Cell Sci (1994) 1.76
Association of focal adhesion kinase with Grb7 and its role in cell migration. J Biol Chem (1999) 1.53
Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem (1998) 1.51
Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation. J Biol Chem (1996) 1.50
Differential regulation of Pyk2 and focal adhesion kinase (FAK). The C-terminal domain of FAK confers response to cell adhesion. J Biol Chem (1998) 1.47
Focal adhesion kinase promotes phospholipase C-gamma1 activity. Proc Natl Acad Sci U S A (1999) 1.46
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin. J Biol Chem (1999) 1.44
Regulated expression of focal adhesion kinase-related nonkinase, the autonomously expressed C-terminal domain of focal adhesion kinase. Mol Cell Biol (1999) 1.42
Differential signaling by the focal adhesion kinase and cell adhesion kinase beta. J Biol Chem (1997) 1.39
Characterization of RAFTK, a novel focal adhesion kinase, and its integrin-dependent phosphorylation and activation in megakaryocytes. Blood (1996) 1.38
The related adhesion focal tyrosine kinase forms a complex with paxillin in hematopoietic cells. J Biol Chem (1996) 1.37
Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J Biol Chem (1997) 1.30
Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation. Mol Biol Cell (1999) 1.29
Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. J Cell Sci (1998) 1.25
Further characterisation of the talin-binding site in the cytoskeletal protein vinculin. J Cell Sci (1992) 1.23
The role of conserved amino acid motifs within the integrin beta3 cytoplasmic domain in triggering focal adhesion kinase phosphorylation. J Biol Chem (1997) 1.23
Interactions between two cytoskeleton-associated tyrosine kinases: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase. J Biol Chem (1999) 1.21
Tyrosine phosphorylation of the related adhesion focal tyrosine kinase in megakaryocytes upon stem cell factor and phorbol myristate acetate stimulation and its association with paxillin. J Biol Chem (1997) 1.05
Regulation of a calcium-dependent tyrosine kinase in vascular smooth muscle cells by angiotensin II and platelet-derived growth factor. Dependence on calcium and the actin cytoskeleton. J Biol Chem (1998) 0.99
Molecular cloning and assignment of FAK2, a novel human focal adhesion kinase, to 8p11.2-p22 by nonisotopic in situ hybridization. Genomics (1996) 0.96
Integrins: emerging paradigms of signal transduction. Annu Rev Cell Dev Biol (1995) 8.88
Tyrosine phosphorylation of paxillin and pp125FAK accompanies cell adhesion to extracellular matrix: a role in cytoskeletal assembly. J Cell Biol (1992) 7.97
Stable association of pp60src and pp59fyn with the focal adhesion-associated protein tyrosine kinase, pp125FAK. Mol Cell Biol (1994) 4.11
Integrin-dependent phosphorylation and activation of the protein tyrosine kinase pp125FAK in platelets. J Cell Biol (1992) 4.06
Identification of sequences required for the efficient localization of the focal adhesion kinase, pp125FAK, to cellular focal adhesions. J Cell Biol (1993) 3.64
Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell (1996) 3.60
EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol (1990) 2.71
Interaction of focal adhesion kinase with cytoskeletal protein talin. J Biol Chem (1995) 2.68
Status epilepticus: an independent outcome predictor after cerebral anoxia. Neurology (2007) 2.67
Paxillin, a tyrosine phosphorylated focal adhesion-associated protein binds to the carboxyl terminal domain of focal adhesion kinase. Mol Biol Cell (1995) 2.57
Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial. Ann Intern Med (1994) 2.45
Successful implementation of guidelines for encouraging the use of beta blockers in patients after acute myocardial infarction. Am J Med (1999) 2.41
Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol (2000) 2.07
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med (1998) 1.89
SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem (1998) 1.77
Direct association of protein-tyrosine phosphatase PTP-PEST with paxillin. J Biol Chem (1998) 1.51
Microinjection of antibodies against talin inhibits the spreading and migration of fibroblasts. J Cell Sci (1992) 1.48
SH2 domain specificity and activity modified by a single residue. Nature (1994) 1.44
The role of focal adhesion kinase binding in the regulation of tyrosine phosphorylation of paxillin. J Biol Chem (1999) 1.44
Clinical and radiologic features of pulmonary edema. Radiographics (1999) 1.44
Tyrosine phosphorylation of the focal adhesion kinase pp125FAK during development: relation to paxillin. J Cell Sci (1993) 1.36
Experimental coexpression of vimentin and keratin intermediate filaments in human melanoma cells augments motility. Am J Pathol (1996) 1.34
Focal adhesion targeting: the critical determinant of FAK regulation and substrate phosphorylation. Mol Biol Cell (1999) 1.29
Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol (1985) 1.29
N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study. Chest (1994) 1.27
Protective effects of hypercapnic acidosis on ventilator-induced lung injury. Am J Respir Crit Care Med (2001) 1.22
Inhibition of the catalytic activity of cell adhesion kinase beta by protein-tyrosine phosphatase-PEST-mediated dephosphorylation. J Biol Chem (2001) 1.13
Fatal cardiac arrhythmias and shock following yew leaves ingestion. Ann Emerg Med (1987) 1.11
NCAM stimulates the Ras-MAPK pathway and CREB phosphorylation in neuronal cells. J Neurobiol (1999) 1.10
Arginine stimulates intestinal cell migration through a focal adhesion kinase dependent mechanism. Gut (2004) 1.07
Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome. Am Rev Respir Dis (1991) 1.06
Permissive hypercapnia impairs pulmonary gas exchange in the acute respiratory distress syndrome. Am J Respir Crit Care Med (2000) 1.05
Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis (1990) 1.04
Negative pressure post-tracheal extubation alveolar hemorrhage. Anesth Analg (2001) 1.03
[Giant cell arteritis affecting the female genital tract. 2 case reports]. J Gynecol Obstet Biol Reprod (Paris) (1982) 1.02
Signals from focal adhesions. Curr Biol (1992) 0.97
Identification of integrin-stimulated sites of serine phosphorylation in FRNK, the separately expressed C-terminal domain of focal adhesion kinase: a potential role for protein kinase A. Biochem J (1997) 0.96
Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: the pH paradox and cytoprotection by glucose, acidotic pH, and glycine. Hepatology (1998) 0.96
Focal adhesion kinase: structure and signalling. J Cell Sci Suppl (1994) 0.96
Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study. J Crit Care (1997) 0.95
Oxidant-antioxidant balance in granulocytes during ARDS. Effect of N-acetylcysteine. Chest (1996) 0.94
Use of botulinum toxin type A to avoid tracheal intubation or tracheostomy in severe paradoxical vocal cord movement. Chest (2000) 0.93
Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients. J Clin Pharmacol (2003) 0.92
Extreme hypercapnia is not a long-term prognostic factor after near-fatal asthma: a 12-year follow-up study. Schweiz Med Wochenschr (1998) 0.86
Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis (1998) 0.86
Skin blood flow reduction induced by cigarette smoking: role of vasopressin. Am J Physiol (1984) 0.85
Haemodynamic and pharmacological effects of the converting enzyme inhibitor CGS 14824A in normal volunteers. Eur J Clin Pharmacol (1985) 0.85
Transdermal clonidine therapy in hypertensive patients. Effects on office and ambulatory recorded blood pressure values. JAMA (1985) 0.84
Long-term clinical experience with enalapril in essential hypertension. J Hypertens Suppl (1983) 0.83
Catheter breaking and embolization after right heart catheterization. Intensive Care Med (1995) 0.83
The noncatalytic domain of protein-tyrosine phosphatase-PEST targets paxillin for dephosphorylation in vivo. J Biol Chem (2000) 0.82
[Fulminant pneumococcal septicemia in splenectomized patients]. Schweiz Med Wochenschr (1981) 0.81
Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock. Shock (2000) 0.81
CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly (2001) 0.80
Oxidative metabolism of circulating granulocytes in adult respiratory distress syndrome. Am J Med (1991) 0.80
Does vasopressin sustain blood pressure of normally hydrated healthy volunteers? Am J Physiol (1984) 0.80
[Carbon monoxide poisoning in children: never trivialize]. Rev Med Suisse Romande (2000) 0.79
Tyrosine phosphorylation of a 120,000 dalton membrane-associated protein by the neural form of pp60c-src, pp60c-src+. Oncogene (1992) 0.79
The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells. Mol Endocrinol (2001) 0.79
Unusual rhombencephalitis in relapsing polychondritis. Ann Rheum Dis (1992) 0.78
Ambulatory blood pressure recording to identify hypertensive patients who truly need therapy. J Chronic Dis (1984) 0.78
Skin blood flow and cigarette smoking: the role of vasopressin. Clin Exp Hypertens A (1984) 0.77
Thymoma, immunodeficiency, and herpes simplex virus infections. Med Mal Infect (2009) 0.77
Deterioration of renal function in hypertensive patients with scleroderma despite blood pressure normalization with captopril. Klin Wochenschr (1984) 0.77
Effectiveness of percutaneous transluminal coronary angioplasty in cardiogenic shock during acute myocardial infarction. Am J Cardiol (1992) 0.76
A potent converting enzyme inhibitor CGS 13928C. Drug profile in normal volunteers. Eur J Clin Pharmacol (1984) 0.76
[Endocarditis due to HACEK bacteria. A case report of endocarditis due to Kingella kingae]. Rev Med Suisse Romande (2001) 0.75
Risks and benefits of therapy with flumazenil (Anexate) in mixed drug intoxications. Eur Neurol (1991) 0.75
Microinjection of protein tyrosine phosphatases into fibroblasts disrupts focal adhesions and stress fibers. Cell Adhes Commun (1998) 0.75
Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia. Br Heart J (1986) 0.75
Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction. Am J Cardiol (1993) 0.75
Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physicians. Clin Exp Hypertens A (1985) 0.75
Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor. Horm Metab Res (1986) 0.75
Life-threatening asthma with dramatic resolution. Chest (1993) 0.75
Anaphylactoid purpura like vasculitis following fibrinolytic therapy: role of the immune response to streptokinase. Clin Exp Rheumatol (1994) 0.75
[The pulmonary manifestations of diving accidents]. Schweiz Z Sportmed (1993) 0.75
[Discontinuation of chronic hemodialysis due to improved kidney function caused by the control of arterial hypertension]. Schweiz Med Wochenschr (1979) 0.75
[Therapeutic use of N-acetylcysteine in acute lung diseases]. Rev Mal Respir (1999) 0.75
[Vasopressin in acute myocardial infarct: clinical implications]. Schweiz Med Wochenschr (1986) 0.75
[Usefulness of the Remler device in avoiding overtreatment of the so-called hypertensive population]. Schweiz Med Wochenschr (1983) 0.75
[Role of vasopressin in reducing the cutaneous blood flow induced by cigarette smoke]. Schweiz Med Wochenschr (1984) 0.75
[Prognostic value of the renin-angiotensin system in response to salt restriction and prognosis of alcoholic ascitic cirrhosis]. Schweiz Med Wochenschr (1986) 0.75
[Survival of HIV-positive patients hospitalized in intensive care for respiratory insufficiency and pneumocystis carinii pneumonia]. Schweiz Med Wochenschr (1990) 0.75
Cranial nerve palsies and descending paralysis in a drug abuser resulting from wound botulism. Intensive Care Med (1999) 0.75
Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC. J Pharm Biomed Anal (2002) 0.75
[Reduction of skin blood flow by cigarette smoke: role of vasopressin]. Arch Mal Coeur Vaiss (1985) 0.75
[Merging of two intensive care units: preliminary observations]. Rev Med Suisse (2006) 0.75
[Long-term prognosis for patients undergoing thrombolysis during the acute phase of myocardial infarction]. Ann Cardiol Angeiol (Paris) (1997) 0.75
[Treatment of hypertensive crisis with captopril]. Schweiz Med Wochenschr (1983) 0.75
Bilateral breast necrosis after prone position ventilation. Intensive Care Med (2001) 0.75
CD11b/CD18 expression, adherence, and chemotaxis of granulocyte in adult respiratory distress syndrome. Am J Respir Crit Care Med (1994) 0.75
[Rhabdomyolysis, acute renal insufficiency and hypercalcemia]. Schweiz Med Wochenschr (1992) 0.75
[Acute renal insufficiency following inhibition of the angiotensin conversion enzyme by various agents]. Schweiz Med Wochenschr (1984) 0.75
Beclobrate and fatal acute hepatitis. Lancet (1991) 0.75
[Neuroradiological studies in diving accidents]. Schweiz Z Sportmed (1993) 0.75
[Prognosis of acute psychotropic drug poisoning. The Lausanne experience]. Schweiz Med Wochenschr (1982) 0.75
Anisoylated plasminogen streptokinase activator complex versus streptokinase in acute myocardial infarction. Preliminary results of a randomised study. Drugs (1987) 0.75
Recurrent acute quadriplegic myopathy with myosin deficiency. Muscle Nerve (1998) 0.75